首页> 外国专利> NEW COMPOUNDS, PROCESS FOR THEIR PREPARATION, INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF 5-HT6 MEDIATED DISORDERS SUCH AS ALZHEIMER'S DISEASE, COGNITIVE DISORDERS, COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA, OBESITY AND PARKINSON'S DISEASE

NEW COMPOUNDS, PROCESS FOR THEIR PREPARATION, INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF 5-HT6 MEDIATED DISORDERS SUCH AS ALZHEIMER'S DISEASE, COGNITIVE DISORDERS, COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA, OBESITY AND PARKINSON'S DISEASE

机译:新化合物,其制备过程,中间体,药物成分及其在治疗5-HT6介导的疾病中的用途,例如老年痴呆症,认知障碍,合并精神分裂症和肥胖症的认知障碍,肥胖

摘要

The present invention relates to new compounds of formula (I), or salts, solvates or solvated salts thereof, process for their preparation and to new intermediates used in the preparation thereof, pharmaceutical compositions containing said compounds and to the use of said compounds in the treatment of 5-HT6 mediated disorders such as Alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and Parkinson's disease.
机译:本发明涉及式(I)的新化合物,或其盐,溶剂化物或溶剂化物的盐,其制备方法,及其制备中使用的新中间体,含有所述化合物的药物组合物,以及所述化合物在药物治疗中的用途。治疗5-HT6介导的疾病,例如阿尔茨海默氏病,认知障碍,与精神分裂症相关的认知障碍,肥胖症和帕金森氏病。

著录项

  • 公开/公告号EP1910321A4

    专利类型

  • 公开/公告日2010-09-01

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号EP20060758020

  • 申请日2006-07-03

  • 分类号C07D267/14;A61K31/55;A61K31/553;A61P3/04;A61P25/16;A61P25/28;C07D223/16;C07D401/12;C07D401/14;C07D409/12;C07D413/12;C07D417/12;C07D513/04;

  • 国家 EP

  • 入库时间 2022-08-21 18:38:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号